Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

Merit Medical Systems, Inc. (MMSI)

Nasdaq Health Care Health Care Supplies S&P SmallCap 600
$87.23
-2.39 (-2.67%)
Close of Nov 06, 2026 · end-of-day data

MMSI 8-K filings in 2024

Every material Form 8-K Merit Medical Systems filed with the SEC in 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.

Briefs in 2024116 on record in all
Latest filing in 2024Dec 19, 2024leadership
High impact (4-5)1of 1 brief
ToneNeutral1
Dec 19, 4:52 PM ET

Merit Medical President Joseph Wright resigns; Fred Lampropoulos reappointed President

Neutral leadership Written later 5.027.01

Merit Medical President Joseph Wright resigned effective January 3, 2025, after the company received allegations about his conduct that its independent directors investigated with outside counsel. The company says the allegations were unrelated to its operations or financial performance, and CEO Fred Lampropoulos was re-appointed as President.

  • Joseph C. Wright resigned on December 16, 2024, effective January 3, 2025, under a Separation Agreement and Release of All Claims.
  • Wright will forfeit stock options and performance stock units other than vested options and eligible PSUs as of the resignation date.
  • Fred P. Lampropoulos, age 75, the company's CEO since 1987, was re-appointed President; the filing states his compensation has not changed.
  • The filing says the allegations were unrelated to Merit's operations or financial performance; Lampropoulos is Wright's brother-in-law.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Merit Medical Systems filing is on SEC EDGAR ↗. 8-K briefs of other companies →